Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]

Stephan Seitz, Stefan Buchholz, Andrew V. Schally^*, Arumugam R. Jayakumar, Florian Weber, Andrea Papadia, Ferenc G. Rick, Luca Szalontay, Andrea Treszl, Frank Köster, Olaf Ortmann, Florian Hohla